Impact of ERT and follow-up of 17 patients from the same family with a mild form of MPS II
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | STEPHAN, Bruno de Oliveira | |
dc.contributor.author | QUAIO, Caio Robledo | |
dc.contributor.author | SPOLADOR, Gustavo Marquezani | |
dc.contributor.author | PAULA, Ana Carolina de | |
dc.contributor.author | CURIATI, Marco Antonio | |
dc.contributor.author | MARTINS, Ana Maria | |
dc.contributor.author | LEAL, Gabriela Nunes | |
dc.contributor.author | TENORIO, Artur | |
dc.contributor.author | FINZI, Simone | |
dc.contributor.author | CHIMELO, Flavia Teixeira | |
dc.contributor.author | MATAS, Carla Gentile | |
dc.contributor.author | HONJO, Rachel Sayuri | |
dc.contributor.author | BERTOLA, Debora Romeo | |
dc.contributor.author | KIM, Chong Ae | |
dc.date.accessioned | 2022-10-26T14:22:31Z | |
dc.date.available | 2022-10-26T14:22:31Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Mucopolysaccharidosis type II, also known as Hunter syndrome, is a rare X-linked recessive disorder caused by deficiency of the lysosomal enzyme Iduronate-2-Sulfatase (IDS), leading to progressive accumulation of Glycosaminoglycans (GAGs) in several organs. Over the years, Enzyme Replacement Therapy (ERT) has provided significant benefits for patients, retarding the natural progression of the disease. Results: The authors evaluated 17 patients from the same family with a mild form of MPS type II; the proband had developed acute decompensated heart failure refractory to clinical measurements at 23 years and needed a rather urgent heart transplant; however, he died from surgical complications shortly after the procedure. Nevertheless, subsequent to his tragic death, 16 affected male relatives were detected after biochemical tests identifying the low or absent activity of the IDS enzyme and confirmed by molecular analysis of the IDS gene. Following diagnosis, different options of treatment were chosen: 6 patients started ERT with Elaprase (R) (Idursulfase) soon after, while the other 10 remained without ERT. Eventually, 4 patients in the latter group began ERT with Hunterase (R) (Idursulfase Beta). None presented adverse effects to either form of the enzyme. Among the 6 individuals without any ERT, two died of natural causes, after reaching 70 years. Despite the variable phenotype within the same family (mainly heart dysfunctions and carpal tunnel syndrome), all 14 remaining patients were alive with an independent lifestyle. Conclusion: Here, the authors report the variable progress of the disease with and without ERT in a large Brazilian family with a slowly progressive form of MPS II, harboring the same missense variant in the IDS gene. | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.citation | CLINICS, v.77, article ID 100082, 6p, 2022 | |
dc.identifier.doi | 10.1016/j.clinsp.2022.100082 | |
dc.identifier.eissn | 1980-5322 | |
dc.identifier.issn | 1807-5932 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/49196 | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER ESPANA | eng |
dc.relation.ispartof | Clinics | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright ELSEVIER ESPANA | eng |
dc.subject.other | idursulfase beta | eng |
dc.subject.other | hunter-syndrome | eng |
dc.subject.other | hearing-loss | eng |
dc.subject.other | experience | eng |
dc.subject.other | children | eng |
dc.subject.other | adults | eng |
dc.subject.wos | Medicine, General & Internal | eng |
dc.title | Impact of ERT and follow-up of 17 patients from the same family with a mild form of MPS II | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | PAULA, Ana Carolina de:Univ Sao Paulo HCFMUSP, Inst Crianca, Hosp Clin, Fac Med, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | CURIATI, Marco Antonio:Univ Sao Paulo HCFMUSP, Ctr Referencia Erros Inatos Metabol CREIM, Sao Paulo, SP, Brazil | |
hcfmusp.author.external | TENORIO, Artur:Univ Sao Paulo HCFMUSP, Fac Med, Hosp Clin, Oftalmol, Sao Paulo, SP, Brazil | |
hcfmusp.citation.scopus | 4 | |
hcfmusp.contributor.author-fmusphc | BRUNO DE OLIVEIRA STEPHAN | |
hcfmusp.contributor.author-fmusphc | CAIO ROBLEDO D'ANGIOLI COSTA QUAIO | |
hcfmusp.contributor.author-fmusphc | GUSTAVO MARQUEZANI SPOLADOR | |
hcfmusp.contributor.author-fmusphc | ANA MARIA MARTINS | |
hcfmusp.contributor.author-fmusphc | GABRIELA NUNES LEAL | |
hcfmusp.contributor.author-fmusphc | SIMONE FINZI | |
hcfmusp.contributor.author-fmusphc | FLAVIA TEIXEIRA CHIMELO | |
hcfmusp.contributor.author-fmusphc | CARLA GENTILE MATAS | |
hcfmusp.contributor.author-fmusphc | RACHEL SAYURI HONJO KAWAHIRA | |
hcfmusp.contributor.author-fmusphc | DEBORA ROMEO BERTOLA | |
hcfmusp.contributor.author-fmusphc | CHONG AE KIM | |
hcfmusp.description.articlenumber | 100082 | |
hcfmusp.description.volume | 77 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 35882106 | |
hcfmusp.origem.scielo | SCIELO:S1807-59322022000100251 | |
hcfmusp.origem.scopus | 2-s2.0-85134828411 | |
hcfmusp.origem.wos | WOS:000833592000004 | |
hcfmusp.publisher.city | MADRID | eng |
hcfmusp.publisher.country | SPAIN | eng |
hcfmusp.relation.reference | Adam MP, 1993, DIABETES MELLITUS 6Q | eng |
hcfmusp.relation.reference | Chung YK, 2014, GLYCOCONJUGATE J, V31, P309, DOI 10.1007/s10719-014-9523-0 | eng |
hcfmusp.relation.reference | D'Avanzo F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041258 | eng |
hcfmusp.relation.reference | Grinberg H, 2012, CARDIOVASC PATHOL, V21, P358, DOI 10.1016/j.carpath.2011.10.004 | eng |
hcfmusp.relation.reference | Khan SA, 2018, MOL GENET METAB, V125, P44, DOI 10.1016/j.ymgme.2018.04.011 | eng |
hcfmusp.relation.reference | Kim C, 2017, J HUM GENET, V62, P167, DOI 10.1038/jhg.2016.133 | eng |
hcfmusp.relation.reference | Marler JA, 2005, AM J MED GENET A, V138A, P318, DOI 10.1002/ajmg.a.30970 | eng |
hcfmusp.relation.reference | Marler JA, 2010, AM J MED GENET C, V154C, P249, DOI 10.1002/ajmg.c.30262 | eng |
hcfmusp.relation.reference | Martin R, 2008, PEDIATRICS, V121, pE377, DOI 10.1542/peds.2007-1350 | eng |
hcfmusp.relation.reference | Muenzer J, 2011, GENET MED, V13, P95, DOI 10.1097/GIM.0b013e3181fea459 | eng |
hcfmusp.relation.reference | Muenzer J, 2009, PEDIATRICS, V124, pE1228, DOI 10.1542/peds.2008-0999 | eng |
hcfmusp.relation.reference | Ngu LH, 2017, MOL GENET METAB REP, V12, P28, DOI 10.1016/j.ymgmr.2017.05.002 | eng |
hcfmusp.relation.reference | omim, OMIM ONLINE MENDELIA | eng |
hcfmusp.relation.reference | orpha, **DROPPED REF** | eng |
hcfmusp.relation.reference | Parini R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082975 | eng |
hcfmusp.relation.reference | Quaio CRDC, 2012, JIMD REP, V4, P125, DOI 10.1007/8904_2011_90 | eng |
hcfmusp.relation.reference | Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30 | eng |
hcfmusp.relation.reference | SASAKI CT, 1987, LARYNGOSCOPE, V97, P280 | eng |
hcfmusp.relation.reference | Semyachkina AN, 2019, BMC MED GENET, V20, DOI 10.1186/s12881-019-0807-x | eng |
hcfmusp.relation.reference | Stapleton M, 2018, MOL GENET METAB, V125, P4, DOI 10.1016/j.ymgme.2018.01.003 | eng |
hcfmusp.relation.reference | Wraith JE, 2008, GENET MED, V10, P508, DOI [10.1097/GIM.0b013e31817701e6, 10.1097GIM.0b013e31817701e6] | eng |
hcfmusp.relation.reference | Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4 | eng |
hcfmusp.relation.reference | Zarchi O, 2011, J PEDIATR-US, V158, P301, DOI 10.1016/j.jpeds.2010.07.056 | eng |
hcfmusp.scopus.lastupdate | 2024-06-09 | |
relation.isAuthorOfPublication | 81b47406-c05e-4ce6-bb8e-617a97df711d | |
relation.isAuthorOfPublication | d9d8ac9a-1d9b-4108-b1c8-c8888f486705 | |
relation.isAuthorOfPublication | da411408-e128-47ee-995b-88f7b1344447 | |
relation.isAuthorOfPublication | 32109840-b181-4488-95f9-3acd6008d384 | |
relation.isAuthorOfPublication | a3b5e39d-525f-4648-87bb-229222d307ba | |
relation.isAuthorOfPublication | 0d4046a1-8068-4af8-84de-df60811353ff | |
relation.isAuthorOfPublication | 43500250-f121-47ae-a810-610860edce16 | |
relation.isAuthorOfPublication | 0f675654-4d29-45dc-83ad-b227342d3a82 | |
relation.isAuthorOfPublication | f71cc4f0-d44f-412c-a023-edf1c15c7bde | |
relation.isAuthorOfPublication | fc3f0957-77e4-44ad-8653-61f285bfcc94 | |
relation.isAuthorOfPublication | 8715370a-1e5f-4af6-a1c4-ee31748e12a3 | |
relation.isAuthorOfPublication.latestForDiscovery | 81b47406-c05e-4ce6-bb8e-617a97df711d |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_STEPHAN_Impact_of_ERT_and_followup_of_17_patients_2022.PDF
- Tamanho:
- 449 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)
Coleções
Artigos e Materiais de Revistas Científicas - FM/MFT
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/34
Artigos e Materiais de Revistas Científicas - LIM/36
Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/34
Artigos e Materiais de Revistas Científicas - LIM/36